MX2007003953A - Procedimiento de preparacion enantioselectiva de derivados de sulfoxidos. - Google Patents

Procedimiento de preparacion enantioselectiva de derivados de sulfoxidos.

Info

Publication number
MX2007003953A
MX2007003953A MX2007003953A MX2007003953A MX2007003953A MX 2007003953 A MX2007003953 A MX 2007003953A MX 2007003953 A MX2007003953 A MX 2007003953A MX 2007003953 A MX2007003953 A MX 2007003953A MX 2007003953 A MX2007003953 A MX 2007003953A
Authority
MX
Mexico
Prior art keywords
enantioselective
useful
enantioselective preparation
pyridinyl ring
sulphoxide derivatives
Prior art date
Application number
MX2007003953A
Other languages
English (en)
Inventor
Avraham Cohen
Suzy Charbit
Francois Schutze
Frederic Martinet
Patricia Gizecki
Original Assignee
Sidem Pharma S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sidem Pharma S A filed Critical Sidem Pharma S A
Publication of MX2007003953A publication Critical patent/MX2007003953A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La invencion concierne a la preparacion enantioselectiva de derivados de sulfoxidos o de sus sales. El procedimiento consiste en efectuar una oxidacion enantioselectiva de un sulfuro de Formula General (I) a continuacion: A-CH2-S-B (I) es un nucleo piridinilo diversamente sustituido y B es un residuo heterociclico que contiene un nucleo imidazo-piridinilo, por medio de un agente en presencia de un catalizador a base de titanio (IV) y de un ligando constituido por un beta o gama amino-alcohol ciclico en un solvente organico, seguido por una salisificacion por una base. Aplicaciones de la preparacion de utiles en terapeutica.
MX2007003953A 2004-10-05 2005-10-05 Procedimiento de preparacion enantioselectiva de derivados de sulfoxidos. MX2007003953A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0410483A FR2876101B1 (fr) 2004-10-05 2004-10-05 Procede de preparation enantioselective de derives de sulfoxydes
PCT/FR2005/002447 WO2006037894A1 (fr) 2004-10-05 2005-10-05 Procede de preparation enantioselective de derives de sulfoxydes.

Publications (1)

Publication Number Publication Date
MX2007003953A true MX2007003953A (es) 2007-06-14

Family

ID=34949706

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007003953A MX2007003953A (es) 2004-10-05 2005-10-05 Procedimiento de preparacion enantioselectiva de derivados de sulfoxidos.

Country Status (21)

Country Link
US (1) US7528251B2 (es)
EP (1) EP1802620B1 (es)
JP (1) JP5213444B2 (es)
KR (1) KR101258744B1 (es)
CN (1) CN101035787B (es)
AT (1) ATE417848T1 (es)
AU (1) AU2005291156B2 (es)
BR (1) BRPI0516465A (es)
CA (1) CA2580446C (es)
DE (1) DE602005011840D1 (es)
DK (1) DK1802620T3 (es)
ES (1) ES2319804T3 (es)
FR (1) FR2876101B1 (es)
IL (1) IL181831A (es)
MX (1) MX2007003953A (es)
NO (1) NO20071524L (es)
NZ (1) NZ553841A (es)
PL (1) PL1802620T3 (es)
RU (1) RU2380357C2 (es)
WO (1) WO2006037894A1 (es)
ZA (1) ZA200702273B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101012141B (zh) * 2007-02-02 2012-05-23 沈阳药科大学 手性亚砜类化合物的制备方法
FR2925899B1 (fr) * 2007-12-27 2012-12-21 Sidem Pharma Sa Procede de preparation enantioselective de sulfoxydes.
ES2525535T3 (es) * 2009-07-16 2014-12-26 Bayer Intellectual Property Gmbh Procedimiento para la preparación de derivados de 3-triazolil-sulfóxido quirales
RU2448954C1 (ru) * 2010-10-18 2012-04-27 Учреждение Российской академии наук Институт катализа им. Г.К. Борескова Сибирского отделения РАН Способ получения сульфоксидов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
AR030284A1 (es) * 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
WO2003089408A2 (en) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
CN1453278A (zh) * 2002-04-23 2003-11-05 中国人民解放军军事医学科学院放射医学研究所 一种拉唑类化合物及其制备方法与应用
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
CA2512928A1 (en) * 2003-02-24 2004-09-02 Mitsubishi Pharma Corporation The enantiomer of tenatoprazole and the use thereof in therapy

Also Published As

Publication number Publication date
JP5213444B2 (ja) 2013-06-19
EP1802620A1 (fr) 2007-07-04
FR2876101B1 (fr) 2007-03-02
RU2007116816A (ru) 2008-11-20
NZ553841A (en) 2010-09-30
ZA200702273B (en) 2008-06-25
DE602005011840D1 (de) 2009-01-29
NO20071524L (no) 2007-04-27
CA2580446C (fr) 2013-05-21
PL1802620T3 (pl) 2009-07-31
CN101035787A (zh) 2007-09-12
ATE417848T1 (de) 2009-01-15
KR101258744B1 (ko) 2013-04-29
ES2319804T3 (es) 2009-05-12
JP2008515860A (ja) 2008-05-15
WO2006037894A1 (fr) 2006-04-13
CA2580446A1 (fr) 2006-04-13
BRPI0516465A (pt) 2008-09-09
FR2876101A1 (fr) 2006-04-07
IL181831A0 (en) 2007-07-04
EP1802620B1 (fr) 2008-12-17
US20070299261A1 (en) 2007-12-27
AU2005291156B2 (en) 2011-12-22
IL181831A (en) 2011-04-28
US7528251B2 (en) 2009-05-05
KR20070102660A (ko) 2007-10-19
CN101035787B (zh) 2013-03-27
AU2005291156A1 (en) 2006-04-13
RU2380357C2 (ru) 2010-01-27
DK1802620T3 (da) 2009-04-06

Similar Documents

Publication Publication Date Title
CY1122933T1 (el) Ενωσεις θειαζολοκαρβοξαμιδιων και πυριδινοκαρβοξαμιδιου χρησιμες ως αναστολεις κινασης ριμ
WO2008005914A3 (en) Novel glucokinase activators and methods of using same
GB0415746D0 (en) Organic compounds
TW200640913A (en) 5-Substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
MX2012007060A (es) Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria.
WO2007092641A3 (en) Method for substituted 1h-imidazo[4,5-c]pyridines
EA201170093A1 (ru) Замещенные n-оксидпиразиновые производные
SI1802584T1 (sl) Postopki za pripravo substituiranih sulfoksidov
NZ590754A (en) Pyridin-4-yl substituted 2-carboxamide pyrrolidine-amide urea derivatives and their use in the treatment of phosphatidylinositol 3-kinase mediated diseases
MY147749A (en) Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
ATE430743T1 (de) Benzimidazolsubstituierte thiophenderivate, die auf ikk3 wirken
WO2009112677A3 (fr) Dérivés bicycliques de carboxamides azabicycliques, leur préparation et leur application en thérapeutique.
WO2008156159A1 (ja) ジアミン誘導体の製造法
WO2007048847A3 (en) Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases
TW200716518A (en) Acetylene derivatives
IL181831A0 (en) Method for enantioselective preparation of sulphoxide derivatives
TW200612942A (en) Thiazolinone unsubstituted quinolines
IL176914A0 (en) Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
WO2004087702A3 (fr) Procede de preparation enantioselective de derives de sulfoxydes.
Ma et al. Oxidant/solvent-controlled I2-catalyzed domino annulation for selective synthesis of 2-aroylbenzothiazoles and 2-arylbenzothiazoles under metal-free conditions
UA92050C2 (ru) Энантиоселективное получение производных бензимидазола и их солей
IL176915A0 (en) Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
NO20084177L (no) Substituerte Imidazo[2,1-B]thiazolforbindelser og deres anvendelse for produksjon av legemidler
ATE514698T1 (de) Tetracyclische azapyrazinoindoline als 5-ht2- liganden
MXPA05014191A (es) Procedimiento para preparar derivado de acido 3-acilaminobenzofuran-2-carboxilico.

Legal Events

Date Code Title Description
FG Grant or registration